Drug Shortage Report for FLUMAZENIL INJECTION
Report ID | 148857 |
Drug Identification Number | 02266342 |
Brand name | FLUMAZENIL INJECTION |
Common or Proper name | Flumazenil Injection 0.1 mg/mL MD Vial 5 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | FLUMAZENIL |
Strength(s) | 0.1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 mL |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-12-01 |
Actual start date | 2021-12-01 |
Estimated end date | 2022-02-15 |
Actual end date | 2022-02-16 |
Shortage status | Resolved |
Updated date | 2022-02-17 |
Company comments | Fresenius Kabi Canada regrets to advise that due to further production delays we will be extending the backorder on our Flumazenil Injection 0.1 mg/mL MD Vial 5 mL until February 15, 2022. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-11-04 | English | Compare |
v2 | 2021-11-04 | French | Compare |
v3 | 2021-11-30 | English | Compare |
v4 | 2021-11-30 | French | Compare |
v5 | 2021-12-02 | English | Compare |
v6 | 2021-12-09 | English | Compare |
v7 | 2021-12-09 | French | Compare |
v8 | 2021-12-16 | English | Compare |
v9 | 2021-12-16 | French | Compare |
v10 | 2022-01-11 | English | Compare |
v11 | 2022-01-11 | French | Compare |
v12 | 2022-01-24 | English | Compare |
v13 | 2022-01-24 | French | Compare |
v14 | 2022-02-14 | English | Compare |
v15 | 2022-02-14 | French | Compare |
v16 | 2022-02-17 | English | Compare |
Showing 1 to 16 of 16